Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biogen Linked To More Coronavirus Cases In Boston

International Meeting At Center Of Outbreak

Executive Summary

Company has instructed employees and contractors to self isolate to prevent further spread of COVID-19.

You may also be interested in...



In A Volatile Time, Pharma Reassures Business Remains Steady

Amid a stock market freefall spurred largely by coronavirus uncertainty, big pharma sought to reassure investors and the public that supply disruptions are not an immediate concern and they are monitoring business operations day-by-day.

As Coronavirus Tightens Its Grip, US FDA Cancels Some Meetings Due To ‘Extenuating Circumstances’

Agency won't say whether patient-focused drug development meeting and gene therapy conference were postponed because of COVID-19, but other meetings remain as scheduled.

Biopharma’s Coronavirus ‘Self-Isolating’: Companies Cancel Investor Meetings, Cut Back Travel

As the coronavirus spreads beyond China, biopharma companies are taking precautions, with some more wary than others.

Topics

Related Companies

UsernamePublicRestriction

Register

SC141799

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel